Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -48.64%. However, over the past six months, we’ve seen a weaker performance of 36.38%. The price of VERV fallen by 24.96% over the last 30 days. And in the last five days, it has surged by 47.63%.
In terms of market performance, Verve Therapeutics Inc had a fairly uneven. The highest value for the stock in the past year was $19.34 on 02/29/24, and the lowest value was recorded at $4.30 on 08/14/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of VERV Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Verve Therapeutics Inc’s current trading price is -62.98% away from its 52-week high, while its distance from the 52-week low is 66.32%. The stock’s price range during this period has varied between$4.30 and $19.34. The Verve Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 4.42 million for the day, a figure considerably higher than their average daily volume of 1.36 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Verve Therapeutics Inc (VERV) has experienced a quarterly rise of 17.76% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 588.36M and boasts a workforce of 255 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.67, with a change in price of +0.79. Similarly, Verve Therapeutics Inc recorded 1,406,115 in trading volume during the last 100 days, posting a change of +12.40%.
VERV’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VERV stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.12.
VERV Stock Stochastic Average
Verve Therapeutics Inc’s raw stochastic average for the past 50 days is presently 95.55%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 95.44%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 67.12% and 57.06%, respectively.
